Clinical Trial Update: Fenofibrate in Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating fenofibrate for ulcerative colitis is currently recruiting, sponsored by Tanta University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Tanta University | Conditions: Inflammatory Bowel Diseases | Phase 2, Phase 3 | Status: RECRUITING